Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk/IL-21 axis

Dendritic cells (DCs) can process the antigens of cancer vaccine and thus stimulate the CD8(+) T cells to recognize and kill the tumor cells that express these antigens. However, lack of promising carriers for presenting the antigens to DCs is one of the main barriers to the development of clinicall...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Theranostics
Asıl Yazarlar: Gou, Shanshan, Wang, Shuai, Liu, Wenwen, Chen, Guanyu, Zhang, Dongyang, Du, Jiangfeng, Yan, Zhongyi, Wang, Hongfei, Zhai, Wenjie, Sui, Xinghua, Wu, Yahong, Qi, Yuanming, Gao, Yanfeng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ivyspring International Publisher 2021
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8210616/
https://ncbi.nlm.nih.gov/pubmed/34158852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.56406
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller